Medicinova, Inc.

MNOVNASDAQ • USD
1.50 USD
↗ 0.16 (11.57%)🟢PRE MARKET (AS OF 07:18 AM EST)
🟢Market: OPEN

Medicinova, Inc. (MNOV) is currently trading at $1.50. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bullish Golden Cross on the moving averages. MNOV is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Nov 16, 2026.

Open?$1.43
High?$1.51
Low?$1.43
Prev. Close?$1.34
Volume?19
Avg. Volume?63.3K
VWAP?$1.49
Rel. Volume?0.00x
Bid / Ask
Bid?$1.16 × 100
Ask?$1.76 × 100
Spread?$0.60
Midpoint?$1.46
Valuation & Ratios
Market Cap?68.7M
Shares Out?49.2M
Float?40.3M
Float %?81.9%
P/E Ratio?N/A
P/B Ratio?1.67
EPS?-$0.21
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.
Employees
6
Market Cap
68.7M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2006-12-07
Address
4275 EXECUTIVE SQUARE
LA JOLLA, CA 92037
Phone: 858-373-1500
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
90
Short Sent.?
78
Piotroski F-Score?2/9Weak
Altman Z-Score?-4.00Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?0.71%Low
Short Interest?285.2K
Days to Cover?5.4
Free Float40.3M
Avg Daily Volume52.5K
Settlement Date2026-10-30
Financial Health
Current Ratio?8.75Strong
Quick Ratio?8.75Strong
Cash Ratio?8.47Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
83
1.67CHEAP▾
P/S?
Peers
100
S&P
3
73.37HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-3.4CHEAP▾
EV/Sales?
Peers
100
S&P
3
42.10HIGH▾
Returns & Efficiency
ROE?
S&P
7
-25.7%WEAK▾
ROA?
S&P
3
-23.3%WEAK▾
Cash Flow & Enterprise
FCF?$-9803321
Enterprise Value?$39.4M
Fundamentals ratios updated end of day